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ABSTrACT
The main objectives in this study were to determine the percentage of psychiatric comorbidity among treatment seeking 
opioid dependents in Klang Valley. A cross sectional study of opioid dependence patients was conducted between 
December 2007 and May 2008 at ten community-based drug substitution therapy clinics in Klang Valley. A total of 204 
opioid dependence patients participated in the study using the structured clinical interview for DSM-IV Axis I disorders 
(SCID-I) as its instruments. The percentage of psychiatric comorbidity among opioid dependents was 43.6%. Major 
depressive disorder had the highest prevalence at 32.6%, followed by dysthymia at 23.6% and Panic disorder at 14.6%. 
Psychiatric comorbidity were found to have significant differences (p<0.05) in connection with history of polysubstance 
abuse, previous history of court sentences (legal status) and family history of psychiatric illnesses. This study showed 
that the percentage of psychiatric comorbidity is high among the opioid dependents. It highlights the urgent need for the 
psychiatric comorbidity to be assessed and early intervention is important for this group of patients.
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ABSTrAK
Objektif utama kajian ini adalah untuk melihat peratusan komorbiditi penyakit psikiatri dalam kalangan penagih yang 
bergantung pada opioid di Lembah Kelang. Kajian rentas ini dilakukan antara bulan Disember 2007 sehingga bulan 
Mei 2008 di sepuluh klinik swasta yang mempunyai program terapi gantian dadah sekitar Lembah Kelang. Sejumlah 
204 penagih opioid menyertai kajian ini menggunakan temuduga klinikal berstruktur untuk disorder paksi 1 DSM-IV 
(SCID-I) untuk melihat sama ada mereka mempunyai komorbiditi. Dilihat 43.6% daripada kumpulan penagih opioid 
ini mempunyai komorbiditi psikiatri. Penyakit Kemurungan mempunyai peratusan tertinggi pada 32.6%, diikuti oleh 
penyakit disthiamia pada 23.6% dan penyakit Panik pada 14.6%. Komorbiditi psikiatri didapati mempunyai perbezaan 
siknifikan (p<0.05) pada sejarah penyalahgunaan pelbagai jenis dadah, sejarah dijatuhi hukuman mahkamah dan 
sejarah penyakit psikiatri dalam kalangan ahli keluarga. Kajian ini menunjukkan peratusan komorbiditi psikiatri 
adalah tinggi. Ini memperlihatkan bahawa amat penting komorbiditi psikiatri dikaji dan intervensi awal penting untuk 
kumpulan pesakit ini.
Kata kunci: Komorbiditi psikiatri; pergantungan pada opioid 
inTrODuCTiOn
There is estimated to be 400000 to 800000 drug users in 
Malaysia and the number is estimated to increase to one 
million in the next few years (hussain 2001). Statistics 
from nADA (2007) showed that 63% of drug abusers in 
Malaysia were opioid users. Currently there is a new 
paradigm shift in the management of heroin dependence in 
Malaysia. in the new policy the addicts were recognized as 
a patient and their rehabilitation were taken care by various 
government departments with specific emphasis towards 
the treatment with opiate substitution therapy. recently, we 
found that there was an increased in the number of heroin 
dependents who sought treatment in community-based 
clinics. This is probably because it is more convenient and 
less stigmatized. however, relapses are still synonymous 
with heroin addiction. Thus, it is important to find factors 
that can contribute to the treatment retention and also 
relapse prevention. Psychiatry comorbidity is identified 
as among the factors that can influence the treatment’s 
efficiency.
 rounsaville et al. (1982) revealed that 80% of opioid 
abusers had comorbid psychiatry diagnosis. however, 
Brooner et al. (1997) found only 47% and rasidi (1992) 
found 49.3% of opioid abusers had co morbid psychiatry 
diagnosis. hein et al. (1997) reported that 67% of patients 
who came for treatment of substance abuse also received 
lifetime diagnoses of serious psychiatric illness. Kaplan 
and Saddock (2003) found that about 90% of persons with 
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opioid dependence have comorbid psychiatric disorders. 
The most common diagnoses were major depressive 
disorder and anxiety disorder. A study by Lintzeris (2001) 
revealed that compared with general population, the 
opioid dependence individual tend to have 7 times greater 
incidence of a psychotic disorder, 9 times greater incidence 
of a diagnosis of depression and 3 times greater incidence 
of a diagnosis of anxiety.
 Kessler et al. (1994) in national comorbidity survey 
replication (nCS-r) noted that major depression has had 
high comorbidity with other disorders particularly anxiety 
disorder and substance misuse disorder. 
 There is a lack of data locally on the proportion 
of psychiatric disorders among opioid dependents in 
Malaysian general practitioner setting. Therefore, the area 
studied is relevant to the clinical practice as it will increase 
mental health awareness among the doctors in order to give 
better services to the patients. it can also help the policy 
makers in making the appropriate and applicable policies. 
Preventive measures can be planned and better treatment 
programs can be set up for the benefit of these drug 
rehabilitated patients. This study aimed to investigate the 
demographic characteristics and estimate the proportion 
of psychiatric disorders among treatment seeking opioid 
dependents.
MeThODS
A cross-sectional design was used in this study whereby 
a total of 204 opioid dependence patients from ten 
outpatient addiction clinics in Klang Valley were involved 
in this study over a six-month period. The respondents 
must fulfill the diagnosis of opioid dependence based 
on DSM-iV, legally registered with the clinic and must 
be at least more than two months on treatment with 
maintenance dose of methadone or buphrenorphine. 
Those who are in the withdrawal or intoxication state 
were excluded from the study. All the respondents were 
assessed using the demographic questionnaires and the 
structured clinical interview for DSM-iV Axis i disorders 
(SCiD-i) to determine the diagnosis of mental disorders. 
universiti Kebangsaan Malaysia Medical Centre ethics 
Committee and the Director General national Anti-
drugs Agency granted permission to conduct the study. 
The permission to interview the patients was obtained 
from the respective general practitioners who were 
involved. informed written consent was taken prior 
to each interview and all the inmates were reassured 
of the confidentiality of the data collected. The data 
collected was analysed using the Statistical Package for 
Social Science (SPSS) version 13.0. Multivariate logistic 
regression analysis was used to examine the relationship 
between multiple significant variables with the psychiatric 
comorbidity of the treatment seeking opioid dependents. 
The p value for statistical analysis was set at 0.05 for level 
of significance.
reSuLTS
DeMOGrAPhy Of The reSPOnDenTS
The mean age of the respondents was 36.5 (s.d +8.0) 
years. Majority of the respondents were male (94.6%), 
Malay (82.8%), Muslims (83.3%) and single (52.0%). 
About 48.5% of the respondents have upper secondary 
education level up to MCe/SPM. nevertheless 5.9% had 
tertiary education up to Diploma/ Degree level. Majority 
(68.1%) of the respondents have full time jobs at time of 
interview, 21.1% doing part-time jobs and 5.4% doing 
odd jobs. Only 5.4% of respondents were unemployed. 
We also see that 50.5% of respondents had family history 
of alcohol use, 46.6% had family history of drug use and 
only 15.2% had family history of psychiatric illness. Most 
of respondents (72.1%) had history of polysubstance 
abuse. The most commonest and prominent substances 
other than opiate were amphetamine type stimulant 
(42.9%), psychotropic pills (38.8%), alcohol (10.9%) 
and cannabis (7.5%). Majority (77.0%) of respondents 
had history of court sentences prior to the interview 
meanwhile 49.6% of respondents had history of been 
detained in both prison and Pusat Serenti (government 
drug-rehabilitation centre), 38.9% to prison and 11.5% 
to Pusat Serenti only. 
PSyChiATry COMOrBiDiTy Of The reSPOnDenTS
The results of this research showed 43.6% of respondents 
were diagnosed to have psychiatric Axis i diagnosis. 58.4% 
of respondents were diagnosed to have mood disorders, 
26.9% were diagnosed to have anxiety disorder, 7.9% 
adjustment disorder and 6.8% psychotic disorder. Major 
depressive disorder (32.6%) is the most common diagnosis 
(Table 1). 
 Psychiatric comorbidity was found to have significant 
differences (p<0.05) in connection with history of 
polysubstance abuse, previous history of court sentences 
(legal status), family history of psychiatric illnesses (Table 
2). However there were no significant association between 
age group (p=0.141), duration of treatment (p=0.175), sex 
of the respondents (p=0.261) and ethnic group (p=0.960) 
with the psychiatric comorbidity. Alongside that, we also 
found there were no statistically significant association 
between religion (p=0.717), marital status (p=0.562), 
educational level (p=0.840) and employment status 
(p=0.694) with psychiatric comorbidity (Table 3).
 Multiple logistic regressions were performed to look 
into the relationship among the significant variables. The 
analysis showed that family history of psychiatric illness 
(Or= 13.85, 95% Ci 4.36-43.99, p<0.001) has shown 
strongest association with psychiatry comorbidity among 
the treatment seeking opioid dependents. Besides that, 
history of polysubstance abuse also has shown significant 
association with psychiatry comorbidity. (Or = 3.15, 95% 
Ci 1.42- 7.01, p=0.005). Thus, family history of psychiatric 
illness and history of polysubstance abuse are predictive 
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factors for psychiatric comorbidity. On the contrary, legal 
status is a potential cofounding factor in this study.
DiSCuSSiOn
This was the first study conducted at ten general 
practitioner’s clinics which practicing drug substituition 
therapy in the State of Selangor and Kuala Lumpur. The 
respondents were free to live, move and work in their 
community. in other words they were taking the treatment 
or drug substitution therapy at or near their home. There 
was a local study done before by rasidi (1992) but it was 
done in the closed government detention centre where the 
patient lived in a secured and controlled community with 
strict supervision.
 The association between opioid dependence and 
psychiatric comorbidity was usually described as dual 
diagnosis. it has become increasing source of clinical 
TABLe 1. Description of respondents according to specific psychiatric diagnoses (n=89)
Psychiatric diagnosis frequency (n) Percent (%)
Adjustment disorders 
 Mood disorders
 Major depressive disorder
 Dysthymia
 Double depression
7
29
21
2
7.9
32.6
23.6
2.2
Anxiety disorders
 Generalized anxiety disorder
 Panic disorder
 Obsessive-compulsive disorder
 Specific phobia
 Simple phobia
8
13
1
1
1
9.0
14.6
1.1
1.1
1.1
Psychotic disorders
 Schizophrenia
 Brief psychotic disorder
3
3
3.4
3.4
Total 89 100.0
TABLe 2. Association between psychiatric morbidity with polysubstance abuse, 
legal status and family history of psychiatric illnesses
n Psychiatric comorbidity df Chi-
square
p-
value
Or (95% 
Confidence interval)Present Absent
Polysubstance abuse
 Present
 Absent
147
57
73(49.7%)
16(28.1%)
74(50.3%)
41(71.9%)
1 7.784 0.005* 2.53(1.30-4.90)
Legal status
 Court sentences
 no court sentences
157
47
75(47.8%)
14(29.8%)
82(52.2%)
33(70.2%)
1 4.756 0.029* 2.16(1.07-4.34)
family history of psychiatric illness
 Present
 Absent 
31
173
27(87.1%)
62(35.8%)
4(12.9%)
111(64%)
1 28.086 <0.001* 12.09(4.04-36.13)
TABLe 3. Multivariate analysis of significant socio demographic variables and psychiatric 
 Comorbidity of treatment seeking opioid dependents
Variable p value Adjusted odd ratio 95% Confidence interval
Lower upper
family history of psychiatric illness <0.001* 13.847 4.359 43.986
Polysubstance abuse 0.005* 3.154 1.42 7.009
Legal status 0.211 0.598 0.268 1.338
R2=0.060
*Denotes significant level at alpha=0.05
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and research interest in addiction and general psychiatric 
specialty. in this study we found that 43.6% of respondents 
were diagnosed to have psychiatric comorbidity. The 
percentage of psychiatry disorder is comparable with 
other studies by Brooner et al. (1997) who found 47% 
have psychiatry disorders by using structured clinical 
interview for DSM-iii-r and local study by rasidi found 
the percentage of psychiatry diagnosis was 49.3% by using 
clinical interview schedule based on iCD 9. in comparison, 
the national Comorbidity Study (nCS) revealed that 72% 
of individuals with a drug use disorder had at least one 
co-occurring psychiatric disorder (Kessler et al. 1994). 
Two studies on opioid abusers described that 80% patients 
met the criteria for at least one psychiatry disorders during 
their lifetime while current disorders have been reported 
in 30%-70% of the patients (Kessler et al. 1996; Limbeek 
et al. 1992; robins et al.1985).
 Analysis of the data showed that mood disorders 
constituted the highest percentage at 58.4%, followed by 
anxiety disorder (26.9%), adjustment disorder (7.9%) and 
psychotic disorder (6.8%). it is comparable with other 
studies on psychiatric diagnosis (Brooner et al. 1997, 
rasidi 1992, rounsaville et al. 1982, rusdi 2006). Western 
studies showed that the lifetime mood disorder in previous 
studies were ranged from 19% (Brooner et al. 1997) to more 
than 53.9% (rousaville et al. 1982). Local study by rasidi 
(1992) showed that neurotic depression was accounted for 
46.5% of the sample population. rusdi (2006) reported the 
lifetime rate of major depressive disorder in his sample 
population was 34%. Brooner et al. (1997) revealed that the 
lifetime prevalence of anxiety disorder was 8.2%. rasidi 
(1992) reported that anxiety neurosis as the second most 
common diagnosis in his population and accounted for 
5.8% the sample population and rusdi (2006) measure 
the lifetime prevalence of anxiety disorder as 28%. As for 
psychotic disorder, Brooner et al. (1997) revealed that the 
life time prevalence as 0.1% and rasidi (1992) measured 
the prevalence of residual schizophrenia as 0.7%. in this 
study both schizophrenia and brief psychotic disorder were 
accounted for 1.5% each per total sample population. A 
study at Peshawar, Pakistan showed that the major co-
morbid psychiatric conditions were major depression 30%, 
generalized anxiety disorder 4%, phobic disorder 4%, panic 
disorder 2% and dysthymic disorder 2%. (Ahmad et al. 
2001). The mixed results might be due to the differences 
in methodological and socio-cultural factors. 
 The result showed that those who had a history of 
polysubstance abuse had 2.53 times higher risk to get 
psychiatric comorbidity compared with those without 
history of polysubstance abuse. A few studies supported 
the association of polysubstance abuse and prevalence of 
psychiatric comorbidity. One of them was the Swiss study 
done by Breslau et al. (1998) who found that heroin addicts 
who smoke have had increase on risk of depression. Trosi 
et al. (1998) also found an increased risk of psychiatric 
disorder with an increased level of cannabis usage among 
italian army. 
 in this reseach we also found that respondents who 
had a history of court sentences had 2.16 times higher 
risk to get psychiatric comorbidity compare with those 
without history of court sentence. This could be due to 
68.1% of them had history of sentenced to prison. Prison 
is a place for people who had committed offence and 
even though the degree of offence might varies they were 
still being placed together. it is possible that the non-
conducive environment could affect individual’s mental 
health (norliza 2004). non-condusive environment 
could also lead to lack of confiding relationship, low 
self-esteem and psychological stress which would 
predisposed to depression. Severe form of noncondusive 
environment also could be seen among prisoners in 
solitary confinement where they exibited the ‘sensory 
deprivation state’ which manifested with severe anxiety, 
tension, disorganized thought, increased suggestibility, 
body illusion and vivid sensory imagery, usually visual 
and sometimes reaching the proportion of hallucinations 
with a delusional quality (Kaplan & Saddock 2003).
 respondents who had family history of psychiatric 
illness had 12.09 times higher risk to get psychiatric 
comorbidity compared with those without family history 
of psychiatric illness. Study about the psychiatric disorders 
among relatives of opiate dependents by rounsaville et al. 
(1991) also noted that there were higher rates of depression 
among them than relatives of normal subjects. 
 A binary logistic regression analysis performed to 
adjust for co-variate and confounder, it was found that 
only family history of psychiatric illness and history of 
polysubstance abuse were have significant associations. 
Legal status as measured by presence of past history 
of court sentence on the other hand might reacted as a 
confounding factors in this study.
 nevertheless, this study has its own limitations. first, 
this is a cross sectional study and therefore the findings could 
only be limited to understanding the associations between 
heroin dependence and the variables studied. We suggested 
that a longitudinal and prospective study to be done in 
the future in order to investigate any causal relationship, 
onset, course and treatment outcome. Second, the sample 
population may not represent the opioid dependents patients 
due to small sample size and limited to 10 private clinics 
in Klang Valley. finally, few variables in this study such as 
duration of substances used, family histories and previous 
legal status were based on retrospective self report which 
gives rise to potential recall bias.
COnCLuSiOn
Dual diagnosis is often associated with severe illness 
course, poor treatment outcome, poor compliance, frequent 
relapses and high service utilisation. Thus, it is important for 
the treating doctors to recognise the psychiatry comorbidity 
in managing their opioid dependents patients. hein et al. 
(1997) suggested that clinician working with patients with 
substance used disorder should assume that most patients 
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have comorbid psychiatric illness. Therefore, screening for 
psychiatric comorbidity should be done regularly among 
this group of population. Other authors (Dansky et al. 1995; 
Lehman et al. 1994) also emphasized the need for routine 
screening and sophisticated understanding of psychiatric 
symptoms in relation to addictive disorders in order to 
provide accurate assessment and appropriate services.
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